DHDiscretionary HealthIndependent market intelligence
For organizationsStart here

Peptide supply-chain evidence

Trace the records behind the market.

FDA listings and Drug Master Files describe regulatory records, not approved products, proven API shipments or verified pharmacy purchases. Country attribution and facility matches retain their original evidence limits. A DMF submission is not an FDA approval; an entity match does not establish a particular supply relationship.

Synchronized October 27, 2026. This is a dated research snapshot; each record retains its source date.

Back to market intelligence →

648 matching source records · source dates retained

ndc listing

Harbin Jixianglong Biotech Co., Ltd. · retatrutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
Retatrutide
Record ID
84385-103_451817b2-450e-3273-e063-6294a90a88ba
Event date
2025-01-09
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3024038751
Import-alert references
3024038751: IA 66-40 published 02/27/2026
Warning-letter references
3024038751: 05/01/2026 CGMP/API/Adulterated and Misbranded Drugs https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/harbin-jixianglong-biotech-co-ltd-723330-05012026 [site-specific]
Inspect source ↗

ndc listing

Aurisco Pharmaceutical Co.,Ltd · tirzepatide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
Tirzepatide
Record ID
16812-104_3e83e027-a491-8777-e063-6294a90a64b1
Event date
2024-10-16
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
FEI matches
3005793293
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Hybio Pharmaceutical Co. Ltd · semaglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
Semaglutide
Record ID
14403-0024_512050b4-394e-6d81-e063-6394a90a5891
Event date
2026-05-06
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
FEI matches
3011090684;3026377169
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

dmf

SHENZHEN READLINE BIOTECH CO LTD · semaglutide

Source snapshot: 2026-10-20

Role
DMF holder
Country
unresolved
Product / subject
SEMAGLUTIDE
Record ID
39791
Event date
2024-04-23
Date meaning
DMF submission (not approval or marketing)
Match basis
unmatched
DMF status (source code)
A
Marketing category
Not established
FEI matches
Not established
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Sinopep-Allsino Biopharmaceutical Co., Ltd. · liraglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
LIRAGLUTIDE
Record ID
76177-018_5a177f50-ebf6-f444-e063-6394a90abd84
Event date
2019-02-01
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3005460102
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Resilience US, LLC · tirzepatide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
United States
Product / subject
tirzepatide
Record ID
83516-0252_3ba09e71-22f0-98d8-e063-6394a90afc9c
Event date
2024-05-15
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
DRUG FOR FURTHER PROCESSING
FEI matches
3006316363
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

El-Peptido (Shanghai) Biopharmaceutical Co., Ltd · CJC-1295

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
CJC-1295 Acetate
Record ID
87370-003_494cfb13-b52e-c853-e063-6294a90ac22b
Event date
2026-01-12
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
FEI matches
3043327690
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

dmf

LIANYUNGANG MINGHAI PHARMACEUTICAL CO LTD · retatrutide

Source snapshot: 2026-10-20

Role
DMF holder
Country
China
Product / subject
RETATRUTIDE API
Record ID
42689
Event date
2025-11-13
Date meaning
DMF submission (not approval or marketing)
Match basis
exact name (firm name)
DMF status (source code)
A
Marketing category
Not established
FEI matches
3040506319
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Huzhou Huida New Material Co., Ltd. · CJC-1295

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
CJC-1295
Record ID
87778-004_550fa4a0-292c-b19a-e063-6394a90a2d61
Event date
2026-06-25
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3043784330
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Qingyuan Chuangtai Biotech Co., LTD · BPC-157

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
BPC-157
Record ID
87803-003_1082f2b1-c086-4aea-9cb0-06266c302fff
Event date
2026-07-22
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3041576182
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

dmf

GUIZHOU UTIDE BIOTECHNOLOGY CO LTD · BPC-157

Source snapshot: 2026-10-20

Role
DMF holder
Country
China
Product / subject
BPC-157 (FREE BASE)
Record ID
44629
Event date
2026-09-22
Date meaning
DMF submission (not approval or marketing)
Match basis
exact name (firm name)
DMF status (source code)
A
Marketing category
Not established
FEI matches
3034655801
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

DARMERICA, LLC · TB-500

Source snapshot: 2026-10-20

Role
NDC labeler
Country
United States
Product / subject
Thymosin Beta-4 Fragment (TB500) Acetate
Record ID
71052-678_5479ac80-5dfd-29de-e063-6294a90afd1f
Event date
2021-04-27
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3012389174
Import-alert references
Not established
Warning-letter references
3012389174: 12/08/2025 CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/darmerica-llc-716152-12082025 [site-specific]
Inspect source ↗

ndc listing

APISTER LIFESCIENCES PRIVATE LIMITED · sermorelin

Source snapshot: 2026-10-20

Role
NDC labeler
Country
India
Product / subject
Sermorelin Acetate
Record ID
87621-017_585d5ee5-e51c-5c1f-e063-6294a90a3bc9
Event date
2026-08-06
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
FEI matches
3017087685
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Qingdao Biopeptek Co., Ltd. · GHK-Cu

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
PREZATIDE COPPER
Record ID
73212-033_47f7acee-40c1-2291-e063-6394a90af694
Event date
2022-01-03
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3009110908
Import-alert references
3009110908: IA 66-79 published 01/16/2026
Warning-letter references
Not established
Inspect source ↗

ndc listing

Jilin Qijian Bio-Pharmaceutical Co., Ltd. · semaglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
Semaglutide
Record ID
85717-003_5b6c1588-dda6-44ca-e063-6294a90ac807
Event date
2026-09-14
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3010814382
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

dmf

AMBIO INC · liraglutide

Source snapshot: 2026-10-20

Role
DMF holder
Country
United States
Product / subject
LIRAGLUTIDE, NON-STERILE, BULK DRUG SUBSTANCE
Record ID
27215
Event date
2013-06-12
Date meaning
DMF submission (not approval or marketing)
Match basis
exact name (firm name)
DMF status (source code)
A
Marketing category
Not established
FEI matches
3010755363
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

dmf

GUIZHOU UTIDE BIOTECHNOLOGY CO LTD · BPC-157

Source snapshot: 2026-10-20

Role
DMF holder
Country
China
Product / subject
BPC-157 ACETATE
Record ID
44617
Event date
2026-09-21
Date meaning
DMF submission (not approval or marketing)
Match basis
exact name (firm name)
DMF status (source code)
A
Marketing category
Not established
FEI matches
3034655801
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

dmf

BEIJING QL BIOPHARMACEUTICAL CO LTD · semaglutide

Source snapshot: 2026-10-20

Role
DMF holder
Country
unresolved
Product / subject
SEMAGLUTIDE
Record ID
38480
Event date
2023-08-01
Date meaning
DMF submission (not approval or marketing)
Match basis
unmatched
DMF status (source code)
A
Marketing category
Not established
FEI matches
Not established
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Resilience US, LLC · tirzepatide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
United States
Product / subject
Tirzepatide
Record ID
83516-0244_3ba1cd7c-9620-1e4d-e063-6394a90a120a
Event date
2024-12-27
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
DRUG FOR FURTHER PROCESSING
FEI matches
3006316363
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Willow Birch Pharma, LLC. · sermorelin

Source snapshot: 2026-10-20

Role
NDC labeler
Country
United States
Product / subject
Sermorelin Acetate
Record ID
10695-200_4a17e456-6842-af34-e063-6294a90ae2b4
Event date
2026-02-05
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
FEI matches
3009864247
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Eli Lilly Italia SPA · tirzepatide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
ITA
Product / subject
tirzepatide
Record ID
54568-346_612549fb-ae56-4f10-a7c2-a9663a634107
Event date
2024-02-06
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
DRUG FOR FURTHER PROCESSING
FEI matches
3002806895
Import-alert references
Not established
Warning-letter references
3002806895: 09/09/2025 False & Misleading Claims/Misbranded https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025; 09/09/2025 False & Misleading Claims/Misbranded https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716462-09092025; 09/09/2025 False & Misleading Claims/Misbranded https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716475-09092025 [company-name match only]
Inspect source ↗

dmf

CHANGZHOU PHARMACEUTICAL FACTORY · semaglutide

Source snapshot: 2026-10-20

Role
DMF holder
Country
China
Product / subject
SEMAGLUTIDE
Record ID
42883
Event date
2025-10-29
Date meaning
DMF submission (not approval or marketing)
Match basis
exact name (firm name)
DMF status (source code)
A
Marketing category
Not established
FEI matches
3002806661
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Pure Peptide Pharmaceuticals Inc. · MOTS-c

Source snapshot: 2026-10-20

Role
NDC labeler
Country
United States
Product / subject
MOTs-C Acetate
Record ID
87551-242_54a1ec4c-74b5-bff0-e063-6394a90abbd7
Event date
2026-05-01
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3043178471
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Chengdu Shengnuo Biopharm Co. Ltd. · liraglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
Liraglutide
Record ID
32861-0003_4b99e2a9-6432-940b-e063-6294a90ade35
Event date
2014-01-20
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3006257504
Import-alert references
3006257504: IA 66-40 published 09/19/2026
Warning-letter references
Not established
Inspect source ↗

ndc listing

Eli Lilly Italia SPA · tirzepatide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
ITA
Product / subject
tirzepatide
Record ID
54568-342_612549fb-ae56-4f10-a7c2-a9663a634107
Event date
2024-02-06
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
DRUG FOR FURTHER PROCESSING
FEI matches
3002806895
Import-alert references
Not established
Warning-letter references
3002806895: 09/09/2025 False & Misleading Claims/Misbranded https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025; 09/09/2025 False & Misleading Claims/Misbranded https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716462-09092025; 09/09/2025 False & Misleading Claims/Misbranded https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716475-09092025 [company-name match only]
Inspect source ↗

ndc listing

Novo Nordisk Production Belgium SA · semaglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
BEL
Product / subject
Semaglutide
Record ID
43835-0057_4bd2261a-5c65-ad3e-e063-6294a90a0d02
Event date
2025-01-01
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
DRUG FOR FURTHER PROCESSING
FEI matches
3007647000
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

dmf

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD · semaglutide

Source snapshot: 2026-10-20

Role
DMF holder
Country
China
Product / subject
SEMAGLUTIDE
Record ID
44386
Event date
2026-09-11
Date meaning
DMF submission (not approval or marketing)
Match basis
exact name (firm name)
DMF status (source code)
A
Marketing category
Not established
FEI matches
3003885745;3003999190
Import-alert references
Not established
Warning-letter references
3003885745: 06/06/2025 CGMP/Finished Pharmaceuticals/Adulterated https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zhejiang-huahai-pharmaceutical-co-ltd-707145-06062025 [company-name match only] | 3003999190: 06/06/2025 CGMP/Finished Pharmaceuticals/Adulterated https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zhejiang-huahai-pharmaceutical-co-ltd-707145-06062025 [company-name match only]
Inspect source ↗

ndc listing

Novo Nordisk A/S · semaglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
DNK
Product / subject
Semaglutide SNAC
Record ID
0420-9530_d23d9180-43ff-4eb1-880c-500bd3a6ee05
Event date
2019-09-20
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
DRUG FOR FURTHER PROCESSING
FEI matches
3000151819;3002807751
Import-alert references
Not established
Warning-letter references
3000151819: 03/05/2026 Postmarketing Adverse Drug Experience Reporting Requirements https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-717576-03052026; 09/09/2025 False & Misleading Claims/Misbranded https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-716495-09092025 [company-name match only] | 3002807751: 03/05/2026 Postmarketing Adverse Drug Experience Reporting Requirements https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-717576-03052026; 09/09/2025 False & Misleading Claims/Misbranded https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-716495-09092025 [company-name match only]
Inspect source ↗

ndc listing

BioVectra Inc. · tirzepatide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
CAN
Product / subject
Tirzepatide
Record ID
63474-700_4869695b-7678-40dc-9057-9b13c1531b0f
Event date
2025-01-27
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3004063541;3015684350
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) · liraglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
Liraglutide
Record ID
14403-0021_29966b4f-b4dc-1551-e063-6294a90a1116
Event date
2024-12-19
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3011090684;3026377169
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

SUN PHARMACEUTICAL INDUSTRIES, INC. · liraglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
United States
Product / subject
Liraglutide
Record ID
62756-927_17b5316c-c7b8-4d44-9ece-bd31ce1aefa5
Event date
2025-12-10
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3009395771
Import-alert references
Not established
Warning-letter references
3009395771: 06/18/2024 CGMP/Finished Pharmaceuticals/Adulterated https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sun-pharmaceutical-industries-limited-677337-06182024; 10/16/2023 CGMP/Active Pharmaceutical Ingredient (API)/Adulterated https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sun-pharmaceutical-industries-ltd-636199-10162023 [company-name match only]
Inspect source ↗

ndc listing

Chengdu Shengnuo Biopharm Co. Ltd. · semaglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
Semaglutide
Record ID
32861-0011_48c17245-e47d-accf-e063-6394a90af211
Event date
2024-04-25
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
FEI matches
3006257504
Import-alert references
3006257504: IA 66-40 published 09/19/2026
Warning-letter references
Not established
Inspect source ↗

ndc listing

Sinopep-Allsino Biopharmaceutical Co., Ltd. · semaglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
Semaglutide
Record ID
76177-022_2b3bdb93-e622-5fc4-e063-6294a90aee0d
Event date
2023-11-01
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3005460102
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Huzhou Huida New Material Co., Ltd. · tesamorelin

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
Tesamorelin Acetate
Record ID
87778-001_54eef6ed-7a1a-4797-e063-6294a90a5a42
Event date
2026-06-24
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3043784330
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Shenzhen Alvantis Pharma Co., Ltd. · retatrutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
RETATRUTIDE
Record ID
84347-003_2e8b3f64-75e5-317d-e063-6394a90ab261
Event date
2025-02-17
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3031629929
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

El-Peptido (Shanghai) Biopharmaceutical Co., Ltd · semaglutide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
SEMAGLUTIDE
Record ID
87370-005_494cfb13-b532-c853-e063-6294a90ac22b
Event date
2026-01-12
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
FEI matches
3043327690
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

dmf

GUIZHOU UTIDE BIOTECHNOLOGY CO LTD · KPV

Source snapshot: 2026-10-20

Role
DMF holder
Country
China
Product / subject
KPV ACETATE
Record ID
44630
Event date
2026-09-22
Date meaning
DMF submission (not approval or marketing)
Match basis
exact name (firm name)
DMF status (source code)
A
Marketing category
Not established
FEI matches
3034655801
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Pure Peptide Pharmaceuticals Inc. · cathelicidin LL-37

Source snapshot: 2026-10-20

Role
NDC labeler
Country
United States
Product / subject
LL-37 Acetate
Record ID
87551-221_549f6752-5cd1-8f78-e063-6394a90a1e82
Event date
2026-05-01
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3043178471
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Hybio Pharmaceutical Co., Ltd. · tirzepatide

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
Tirzepatide
Record ID
14403-0020_40de9ccb-2ceb-3bba-e063-6294a90a5d2e
Event date
2024-06-26
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3011090684;3026377169
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗

ndc listing

Shenzhen Alvantis Pharma Co., Ltd. · BPC-157

Source snapshot: 2026-10-20

Role
NDC labeler
Country
China
Product / subject
BPC-157
Record ID
84347-102_2e8b3f64-75e5-317d-e063-6394a90ab261
Event date
2025-02-17
Date meaning
listing marketing start (not approval)
Match basis
exact name (firm name)
DMF status (source code)
Not established
Marketing category
BULK INGREDIENT
FEI matches
3031629929
Import-alert references
Not established
Warning-letter references
Not established
Inspect source ↗